Home> Products> betahistine hcl 16mg

{ "products": [ { "_id": "666996c1c91739182c9558aa", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "HISTBETALITE 16 ", "description": "HISTBETALITE 16 \nBetahistine HCL\nIntroduction:\n\nHISTBETALITE 16 contains Betahistine HCL (16mg), a medication commonly used to treat vertigo and Meniere's disease. Betahistine is known for its ability to improve blood flow in the inner ear, reducing the symptoms of vertigo, tinnitus, and hearing loss associated with Meniere's disease.\n\nKey Features and Benefits:\n\nVertigo Relief: Betahistine is effective in reducing the severity and frequency of vertigo episodes. It helps patients regain balance and reduces dizziness, making daily activities easier and safer.\nMeniere's Disease Management: It provides significant relief from the symptoms of Meniere's disease, including vertigo, tinnitus (ringing in the ears), and hearing loss.\nImproved Inner Ear Blood Flow: Betahistine works by increasing blood flow to the inner ear, which helps reduce the pressure that can cause vertigo and other symptoms.\nHistamine Analog: Betahistine is a histamine analog that works by blocking certain receptors and increasing the levels of histamine in the brain, which can help improve vestibular function and reduce vertigo symptoms.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of HISTBETALITE 16 (Betahistine HCL 16mg) is one tablet taken three times daily. Dosage may vary based on the severity of symptoms and the individual patient's response to treatment.\nAdministration: The tablet should be taken orally with water, preferably with food to reduce stomach upset.\nDosage Adjustment: Your healthcare provider may adjust the dosage based on your response to treatment and individual needs. It's important to follow your doctor's instructions regarding dose changes\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/histbetalite-16-134124", "price": 95.0, "discountamount": 28.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "ears", "food", "Order", "EMAIL", "water", "brain", "doctor", "levels", "ability", "balance", "Meniere", "pressure", "patients", "severity", "Benefits", "tinnitus", "response", "treatment", "dizziness", "frequency", "receptors", "medication", "one tablet", "information", "instructions", "sterispharma", "sterisonline", "HISTBETALITE", "dose changes", "hearing loss", "Key Features", "Introduction", "CALL/WHATSAPP", "stomach upset", "Administration", "Initial Dosage", "Vertigo Relief", "other symptoms", "Histamine Analog", "vertigo symptoms", "daily activities", "vertigo episodes", "individual needs", "Dosage Adjustment", "significant relief", "Disease Management", "individual patient", "vestibular function", "healthcare provider", "Betahistine HCL 16mg", "typical starting dose", "Improved Inner Ear Blood Flow" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1835, "imageuri": "https://productimages.withfloats.com/actual/666996c5492d7ea0ab9eded9.png", "tileimageuri": "https://productimages.withfloats.com/tile/666996c5492d7ea0ab9eded9.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T12:38:25.975Z", "updatedon": "2024-06-26T10:38:20.384Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/histbetalite-16-/1835", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "HISTBETALITE 16 ", "category": "NEUROLOGY RANGE", "tags": [ "betahistine side effects", "HISTBETALITE 16", "betahistine side effects blood pressure", "betahistine dose for vertigo", "betahistine dosage 16mg", "betahistine 16 mg uses", "betahistine 16 मिलीग्राम" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6655a9e04d19c318441f42ad", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CANDISTRUM 16", "description": "CANDISTRUM 16\nCandesartan (16mg)\nCandistrum 16 (Candesartan 16mg) is a medication primarily prescribed to manage high blood pressure (hypertension) and heart failure. Candesartan, the active ingredient, works by blocking the action of angiotensin II, a substance in the body that narrows blood vessels, thereby lowering blood pressure and improving blood flow. This medication is typically taken orally once daily, with or without food, as directed by a healthcare professional. It's important to follow the prescribed dosage and not to abruptly stop taking the medication without consulting a doctor, as sudden discontinuation can lead to a rebound increase in blood pressure. Common side effects may include dizziness, headache, and fatigue. If you experience severe side effects such as fainting, difficulty breathing, or swelling of the face, lips, or throat, seek medical attention immediately. Additionally, inform your healthcare provider about any other medications or supplements you are taking, as they may interact with Candistrum 16.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n", "price": 188.0, "discountamount": 57.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "lips", "face", "body", "food", "action", "dosage", "doctor", "throat", "fatigue", "headache", "fainting", "swelling", "substance", "dizziness", "difficulty", "blood flow", "CANDISTRUM", "supplements", "hypertension", "heart failure", "blood vessels", "angiotensin II", "rebound increase", "Candesartan 16mg", "other medications", "medical attention", "active ingredient", "healthcare provider", "high blood pressure", "severe side effects", "Common side effects", "sudden discontinuation", "healthcare professional" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1218, "imageuri": "https://productimages.withfloats.com/actual/6655aa027c5d817bcbce28bf.png", "tileimageuri": "https://productimages.withfloats.com/tile/6655aa027c5d817bcbce28bf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-28T09:54:40.943Z", "updatedon": "2024-06-07T12:53:45.019Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/candistrum-16/1218", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Candesartan (16mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "663896839c15d9142485cfab", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "HISTBETALITE 16 ", "description": "HISTBETALITE 16 \nBetahistine HCL\nHistbetalite 16 contains Betahistine HCL, an effective medication used to treat vertigo and balance disorders. It works by improving blood flow in the inner ear, reducing vertigo symptoms like dizziness, spinning sensation, and balance problems. Histbetalite 16 is prescribed for conditions such as Meniere's disease and vestibular disorders. It is available in 16mg strength tablets. Always follow your doctor's dosage instructions for optimal results and consult them for any concerns or side effects.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n", "price": 95.0, "discountamount": 29.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "doctor", "disease", "Meniere", "concerns", "inner ear", "sensation", "dizziness", "blood flow", "conditions", "side effects", "HISTBETALITE", "Betahistine HCL", "optimal results", "balance problems", "vertigo symptoms", "dosage instructions", "effective medication", "vestibular disorders", "16mg strength tablets" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1133, "imageuri": "https://productimages.withfloats.com/actual/663896b4c76b7398ff890338.png", "tileimageuri": "https://productimages.withfloats.com/tile/663896b4c76b7398ff890338.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-06T08:36:19.978Z", "updatedon": "2024-06-11T12:07:37.582Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/histbetalite-16-/1133", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Betahistine HCL", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662f77c7f590fc18c42c2661", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "STERIMMUNE COUGH COLD ", "description": "STERIMMUNE COUGH COLD \nParacetamol 250mg , Phenylephirine hcl 5mg , Chlorpheniramine Maleate 2mg , Ammonium Chloride 120mg ,And Menthol 1mg\nSterimmune Cough Cold is a comprehensive medication designed to effectively alleviate symptoms associated with coughs and colds. Each tablet contains a precise combination of active ingredients, carefully formulated to provide relief and promote recovery. Here's a detailed description of the key components:\n\nParacetamol 250mg: This ingredient acts as an analgesic and antipyretic, helping to reduce pain and fever commonly associated with colds and flu.\nPhenylephrine HCl 5mg: Known for its decongestant properties, Phenylephrine helps relieve nasal congestion by constricting blood vessels in the nasal passages, making breathing easier.\nChlorpheniramine Maleate 2mg: This antihistamine works to alleviate symptoms like runny nose, watery eyes, and sneezing caused by histamine release during colds and allergies.\nAmmonium Chloride 120mg: An expectorant, Ammonium Chloride helps loosen and expel mucus from the respiratory tract, making coughs more productive and relieving chest congestion.\nMenthol 1mg: Known for its cooling sensation and mild anesthetic properties, Menthol provides soothing relief for sore throat and helps ease breathing by opening up airways.\nSterimmune Cough Cold is a trusted choice for individuals seeking effective relief from the discomforts of coughs and colds. It is recommended to follow the prescribed dosage and consult a healthcare professional if symptoms persist or worsen.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n", "price": 85.0, "discountamount": 26.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "flu", "pain", "mucus", "colds", "fever", "dosage", "coughs", "tablet", "airways", "recovery", "symptoms", "sneezing", "analgesic", "allergies", "breathing", "runny nose", "sore throat", "discomforts", "Menthol 1mg", "watery eyes", "expectorant", "individuals", "antipyretic", "blood vessels", "antihistamine", "trusted choice", "key components", "nasal passages", "soothing relief", "effective relief", "chest congestion", "nasal congestion", "Paracetamol 250mg", "cooling sensation", "respiratory tract", "histamine release", "Ammonium Chloride", "Phenylephrine HCl", "Phenylephirine hcl", "active ingredients", "precise combination", "detailed description", "STERIMMUNE COUGH COLD", "healthcare professional", "decongestant properties", "comprehensive medication", "Chlorpheniramine Maleate", "mild anesthetic properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 821, "imageuri": "https://productimages.withfloats.com/actual/662f77c9070f128ecff68361.png", "tileimageuri": "https://productimages.withfloats.com/tile/662f77c9070f128ecff68361.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-29T10:34:47.172Z", "updatedon": "2024-06-12T12:53:16.551Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sterimmune-cough-cold-/821", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Paracetamol 250mg , Phenylephirine hcl 5mg , Chlorpheniramine Maleate 2mg , Ammonium Chloride 120mg ,And Menthol 1mg", "category": "PEDIATRICS", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662f655ccee6340570616be6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELMISTRUM AZ 16 ", "description": "TELMISTRUM AZ 16 \nTelmisartan (40mg) & Azelnidipine (16mg)\nTelmistrum AZ 16 is a combination medication containing Telmisartan (40mg) and Azelnidipine (16mg). Telmisartan belongs to a class of drugs called angiotensin receptor blockers (ARBs), which help relax blood vessels to lower blood pressure. Azelnidipine is a calcium channel blocker that also helps to widen blood vessels, reducing blood pressure. This combination is used to treat hypertension (high blood pressure) and can help manage cardiovascular conditions. It's essential to follow your doctor's dosage instructions and monitor blood pressure regularly while taking Telmistrum AZ 16.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n", "price": 285.0, "discountamount": 86.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "ARBs", "class", "drugs", "doctor", "Telmisartan", "Azelnidipine", "hypertension", "blood vessels", "TELMISTRUM AZ", "receptor blockers", "high blood pressure", "dosage instructions", "combination medication", "calcium channel blocker", "cardiovascular conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 807, "imageuri": "https://productimages.withfloats.com/actual/662f655ff86c61bb1765538e.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/662f655ff86c61bb1765538e.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-29T09:16:12.246Z", "updatedon": "2024-06-12T12:57:49.446Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/telmistrum-az-16-/807", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Telmisartan (40mg) & Azelnidipine (16mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662b754818870a17183d43ec", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CANDISTRUM 16 ", "description": "CANDISTRUM 16 \nCandesartan (16mg)\nCANDISTRUM 16 is an antifungal medication primarily used to treat candidiasis and other fungal infections. It works by inhibiting the synthesis of ergosterol, a critical component of fungal cell membranes, effectively stopping the growth and spread of fungal cells. CANDISTRUM 16 is ideal for patients seeking a reliable treatment for infections like thrush, yeast infections, and systemic candidiasis. With its targeted action, it ensures rapid relief from symptoms and helps prevent recurrence. Suitable for adults and supervised treatment in children, it's commonly administered in situations where first-line therapies have not been successful.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n", "price": 188.0, "discountamount": 57.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "adults", "thrush", "spread", "growth", "symptoms", "patients", "children", "synthesis", "CANDISTRUM", "recurrence", "ergosterol", "situations", "Candesartan", "rapid relief", "fungal cells", "targeted action", "yeast infections", "reliable treatment", "critical component", "first-line therapies", "systemic candidiasis", "antifungal medication", "fungal cell membranes", "other fungal infections" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 747, "imageuri": "https://productimages.withfloats.com/actual/662b754bcf52ae8ffbe3a416.png", "tileimageuri": "https://productimages.withfloats.com/tile/662b754bcf52ae8ffbe3a416.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T09:35:04.74Z", "updatedon": "2024-06-07T12:27:39.634Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/candistrum-16-/747", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Candesartan (16mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6948f4ee5837f90c86a7e578", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Elagolix Tablets 200mg ", "description": "Eligolux200 contains 200 mg of elagolix per tablet and is manufactured by Steris Healthcare Pvt Ltd in India as a prescription medication in packs of 3x10 tablets. Elagolix acts as a potent gonadotropin-releasing hormone (GnRH) receptor antagonist, binding competitively to GnRH receptors in the pituitary gland to rapidly reduce estrogen and progesterone levels without the initial flare-\nup seen in agonists. This mechanism starves endometrial-like tissue outside the uterus of hormonal stimulation, shrinking lesions and easing inflammation.\n​\n\nAdminister Eligolux200 orally, swallowed whole with water, with or without food, typically starting within 7 days of menstrual onset. Standard dosing for severe cases involves 200mg twice daily for up to 6 months, or 150mg once daily extended to 24 months, adjusted by physicians based on tolerance and response. Store in a cool, dry place away from moisture and light, keeping out of children's reach.\n​\n\nPrimary Uses\nEligolux200 targets moderate to severe endometriosis-associated pain, including dysmenorrhea (painful periods), nonmenstrual pelvic pain, and dyspareunia (painful intercourse). Endometriosis affects millions globally, causing tissue similar to the uterine lining to grow ectopically, leading to chronic inflammation, adhesions, and scarring. By dosing flexibly, Eligolux200 suits patients needing stronger suppression for intense symptoms, reducing reliance on opioids or surgery.\n​\n\nClinical trials like Elaris EM-I and EM-II showed 75% dysmenorrhea reduction and 50-60% nonmenstrual pain relief at 6-12 months. It also curbs heavy menstrual bleeding in uterine fibroids, offering dual benefits for overlapping conditions. Physicians prescribe it when first-line NSAIDs or oral contraceptives fail, prioritizing non-invasive symptom control.\n​\n\nKey Benefits\nEligolix in Eligolux200 delivers rapid pain relief, with significant improvements in daily pain scales within 3 months versus placebo. Women report 47% better composite pelvic pain scores, enhancing daily activities, work productivity, and intimacy. Quality-of-life metrics improve consistently over 24 weeks, including reduced fatigue and better emotional well-being.\n​\n\nUnlike injectables, its oral form and dose-dependent estrogen suppression allow titration—lower doses minimize hypoestrogenic effects while higher 200mg dosing tackles severe pain. Studies confirm amenorrhea in 25% of users early on, slashing bleeding days by up to 50%. Long-term data up to 12 months with add-back therapy sustains efficacy, preserving bone health better than monotherapy. Patients regain control, avoiding invasive laparoscopies and reclaiming normalcy.\n​\n\nBenefit\tEvidence from Trials'\tImpact on Patients\nDysmenorrhea Reduction:\t75% at 6 months \n​\tFewer missed workdays\nNonmenstrual Pain Relief:\t50-60% improvement \n​\tEnhanced mobility\nBleeding Control:\t14% bleeding days vs. 24% baseline \n​\tImproved hygiene, anemia prevention\nQuality of Life\tSustained over 24 weeks \n​\tBetter sleep, relationships\nPotential Side Effects\nCommon side effects of Eligolux200 mirror hypoestrogenic states: hot flashes, night sweats, headache, and nausea, each affecting about 10% of users. These often lessen as the body adjusts, with 69.5% overall adverse event rate over 24 weeks, mostly mild. Mood changes like irritability or depression occur less commonly, warranting mood monitoring.\n​\n\nBone mineral density (BMD) loss poses a key concern—200mg twice daily causes -1.5% to -2.4% drops at lumbar spine and hip after 6 months, attenuated with calcium/vitamin D or add-back therapy. Rare serious risks include suicidal thoughts, liver enzyme elevations, or allergic reactions like anaphylaxis. Discontinuation due to events stays low at 4-12%. No deaths are linked directly to treatment in trials.\n​\n\nSide Effect Category\tFrequency\tManagement\nVasomotor (Hot Flashes)\t9.9-10% \n​\tLifestyle cooling, dose adjustment\nNeurologic (Headache)\t9.9% \n​\tHydration, analgesics\nBone Loss\tUp to 2.4% at 6 months \n​\tDEXA scans, supplements\nMood Changes\tLess common \n​\tPsychiatric screening\nPrecautions and Contraindications\nAvoid Eligolux200 in pregnancy (risk of early loss), known osteoporosis, severe hepatic impairment, or with strong OATP1B1 inhibitors like cyclosporine or gemfibrozil. Women of childbearing age need effective non-hormonal contraception during and 28 days post-therapy, as it impairs recognition of pregnancy via amenorrhea. Not for pediatrics under 18 or geriatrics lacking data.\n​\n\nScreen for depression history, liver function, and BMD before starting; monitor quarterly. Drug interactions abound with rifampin (reduces levels) or over 50 others like clarithromycin—inform physicians fully. Breastfeeding lacks safety data; weigh risks. Regular blood/urine tests track efficacy and safety.\n​\n\nDosage Guidelines\nInitiate Eligolux200 at 150mg daily for milder cases, escalating to 200mg BID for dyspareunia or severe pain, max 6 months at higher dose. Miss a dose? Take promptly unless near next; never double. Duration caps at 24 months total, with liver-adjusted lower dosing. Pair with add-back for extended use to curb BMD loss.\n​\n\nPhysicians tailor based on response: 74-77% complete 6-month trials. Swallow intact; no crushing.\n​\n\nClinical Evidence\nPhase III trials (Elaris EM-I/II) randomized 1689 women, proving both doses superior to placebo for co-primary endpoints of dysmenorrhea and nonmenstrual pain. Open-label extensions to 24 weeks maintained gains. A 12-month study with add-back showed persistent relief and <1% additional BMD loss versus placebo. Real-world use echoes this, positioning Eligolix as first oral GnRH antagonist approved for endometriosis.\n​\n\nVersus relugolix, Eligolix offers comparable pelvic pain reduction with adjustable dosing. Indian brands like Eligolux200 align with global standards.\n​\n\nConclusion\nEligolux200 transforms endometriosis management, delivering substantial pain relief and functional gains through precise hormonal control. Balancing robust benefits against manageable risks like BMD monitoring empowers women toward symptom-free lives. Consult healthcare providers for personalized integration into care plans.\n", "price": 1.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2251, "imageuri": "https://productimages.withfloats.com/actual/6948f4f0fe408c85572e7619.png", "tileimageuri": "https://productimages.withfloats.com/tile/6948f4f0fe408c85572e7619.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T07:36:14.316Z", "updatedon": "2025-12-22T07:36:14.316Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/elagolix-tablets-200mg-/2251", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 200", "category": "GYNEACOLOGY", "tags": [ "Elagolix Tablets 200mg", "Elagolix acts as a potent gonadotropin-releasing hormone.", "nonmenstrual pelvic pain.", "adhesions, and scarring", "preserving bone health better than monotherapy.", "avoiding invasive laparoscopies and reclaiming normalcy.", "pituitary gland to rapidly reduce estrogen and progesterone." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948e738796e72bd2659934b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Micronized Purified Flavonoid Fraction MPFF Tablets 450mg Diosmin+50mg Hesperidin", "description": "Product Name: FLAVOSHIELD 500\nActive Ingredients: Micronized Purified Flavonoid Fraction (MPFF) 500mg, containing Diosmin 450mg and Hesperidin 50mg.\nPresentation: Oral Tablets\n\nUnveiling FLAVOSHIELD 500: A Deep Dive into Advanced Venous and Vascular Wellness\nIn the intricate network of the human circulatory system, veins perform the silent, relentless task of returning blood to the heart against gravity. When this system faces strain, it can manifest through discomfort, heaviness, and visible changes that impact both physical well-being and quality of life. Enter FLAVOSHIELD 500, a sophisticated pharmaceutical-grade formulation designed to fortify venous health at its core. Powered by a Micronized Purified Flavonoid Fraction (MPFF)—a precise blend of 450mg Diosmin and 50mg Hesperidin—FLAVOSHIELD 500 represents a pinnacle in venoactive therapy. This comprehensive description explores the product, its mechanism, multifaceted uses, key benefits, safety profile, and its role in a holistic health strategy.\n\nWhat is FLAVOSHIELD 500? The Science of MPFF\nFLAVOSHIELD 500 is not a simple herbal supplement; it is a clinically researched, standardized medical treatment. Its active core, the Micronized Purified Flavonoid Fraction, is derived from citrus fruits but undergoes a specialized purification and micronization process. This technological advancement is crucial:\n\nPurification: Ensures a consistent, high-potency concentration of the active flavonoid molecules, Diosmin and Hesperidin, free from plant impurities.\nMicronization: Reduces the particle size of the flavonoids dramatically, increasing their surface area. This leads to significantly enhanced absorption in the gastrointestinal tract, ensuring that a much higher percentage of the active dose reaches the bloodstream and, ultimately, the target venous tissues. Compared to non-micronized diosmin, MPFF offers up to 30% greater bioavailability, making FLAVOSHIELD 500 a more effective and reliable choice.\nThis synergy of Diosmin and Hesperidin works on multiple physiological pathways to restore venous tone and capillary integrity.\n\nPrimary Uses and Therapeutic Applications\nFLAVOSHIELD 500 is indicated for the management of various stages of chronic venous disorders and related conditions:\n\nChronic Venous Disease (CVD) & Venous Insufficiency: This is the primary use. It alleviates the distressing symptoms stemming from weakened vein walls and faulty valves in the legs. These include:\n\nHeaviness and Fatigue: The pervasive feeling of weight and tiredness in the legs, especially after prolonged standing or sitting.\nPain and Aching: Dull, throbbing, or cramping pain that improves with elevation.\nSwelling (Edema): Reduction of ankle and lower leg swelling caused by fluid leakage from capillaries.\nNocturnal Cramps: Relief from painful muscle spasms that often occur at night.\nHemorrhoidal Disease (Acute and Chronic): MPFF is a cornerstone in hemorrhoid management. It treats acute hemorrhoidal attacks by reducing bleeding, pain, and discharge. For chronic cases, it helps prevent recurrences by decreasing capillary fragility and inflammation in the anal venous plexus.\n\nPost-Phlebitic Syndrome: Following deep vein thrombosis (DVT), patients often suffer from chronic leg swelling, pain, and skin changes. FLAVOSHIELD 500 can be part of the management plan to improve microcirculation and reduce symptoms.\n\nSupport Post-Sclerotherapy or Surgical Procedures: It is commonly used after vein stripping, laser ablation, or sclerotherapy to support healing, reduce postoperative swelling and bruising, and help consolidate results.\n\nKey Benefits and Mechanism of Action: The Multi-Target Approach\nThe efficacy of FLAVOSHIELD 500 stems from its multi-faceted pharmacological actions on the venous and lymphatic systems:\n\nVenotonic Action: It increases venous tone and elasticity by promoting the contraction of smooth muscle in the vein walls. This helps veins propel blood more efficiently upward, reducing pooling and pressure. Think of it as “tightening” slackened venous structures.\n\nCapillary-Protective & Anti-Inflammatory Effects: It strengthens capillary walls (reduces capillary permeability) and inhibits the release of inflammatory mediators (like prostaglandins and leukotrienes). This dual action minimizes the leakage of fluid, proteins, and inflammatory cells into surrounding tissues, thereby directly addressing edema (swelling) and inflammation. This is particularly vital in hemorrhoidal tissue.\n\nLymphatic Enhancement: FLAVOSHIELD 500 has been shown to increase lymphatic drainage by boosting the frequency and intensity of lymphatic contractions. This provides an additional route for removing excess interstitial fluid and proteins, further reducing swelling.\n\nAntioxidant Activity: The flavonoids scavenge harmful free radicals, protecting venous and capillary endothelial cells from oxidative stress, which is a contributing factor in chronic venous disease.\n\nImprovement of Microcirculation: By reducing blood viscosity and inhibiting red blood cell aggregation, it improves blood flow in the smallest vessels, enhancing oxygen delivery and waste removal at the tissue level.\n\nPatient-Centric Benefits:\n\nRapid Symptom Relief: Patients often report a noticeable decrease in leg heaviness and pain within the first few weeks of treatment.\nEnhanced Quality of Life: Restores the ability to stand, walk, and engage in daily activities with greater comfort and less discomfort.\nReduced Reliance on Pain Medication: By addressing the underlying inflammation and pain of venous issues and hemorrhoids, it can decrease the need for NSAIDs.\nComplement to Compression Therapy: Works synergistically with compression stockings, often allowing for better tolerance and compliance with compression wear.\nSide Effects and Safety Profile: What to Expect\nFLAVOSHIELD 500 is generally very well-tolerated, with a low incidence of side effects, which are typically mild and transient. This excellent safety profile is a result of its natural origin and high purification.\n\nCommon Side Effects (Rare and usually mild):\n\nGastrointestinal: Some individuals may experience mild, transient digestive disturbances such as nausea, stomach pain, diarrhea, or heartburn. Taking the tablet with a meal can often mitigate this.\nNeurological: Occasional reports of headache or dizziness.\nAllergic Reactions: Very rare cases of skin rash or itching have been reported.\nImportant Safety Considerations:\n\nPregnancy and Lactation: While no teratogenic effects have been demonstrated, as a precaution, use during pregnancy (especially the first trimester) and breastfeeding should only be under the direct supervision of a physician who has weighed the benefits against potential risks.\nDrug Interactions: No significant pharmacokinetic drug interactions have been formally reported. However, as with any medication, it is prudent to inform your doctor about all other medicines and supplements you are taking.\nContraindications: Hypersensitivity to any of the components (Diosmin, Hesperidin, or excipients in the tablet) is a contraindication.\nCrucial Note: FLAVOSHIELD 500 is a treatment for symptoms and a stabilizer of venous function, not a cure for underlying venous valve incompetence. It does not replace definitive interventional treatments (like ablation or surgery) for advanced varicose veins when they are medically indicated. It is essential to receive a proper diagnosis from a healthcare professional to rule out other causes of leg swelling or pain (e.g., cardiac, renal, or hepatic origin).\n\nConclusion: FLAVOSHIELD 500 – A Cornerstone of Comprehensive Venous Care\nIn conclusion, FLAVOSHIELD 500 stands as a robust, scientifically validated agent in the realm of vascular health. Its advanced MPFF technology, combining 450mg of micronized Diosmin with 50mg of Hesperidin, delivers enhanced bioavailability and a powerful, multi-target action that addresses the root causes of venous discomfort: poor tone, capillary fragility, inflammation, and impaired lymphatic drainage.\n\nWhether battling the daily fatigue of heavy legs, managing the acute distress of a hemorrhoidal flare-up, or supporting recovery after a venous procedure, FLAVOSHIELD 500 offers a reliable and well-tolerated therapeutic option. Its benefits in improving symptoms and quality of life are clear, backed by a strong body of clinical evidence.\n\nHowever, optimal venous health is a holistic endeavor. FLAVOSHIELD 500 should be viewed as the pharmacological cornerstone of a broader management plan. This plan should include:\n\nMedical Supervision: Regular consultation with a vascular specialist or phlebologist.\nLifestyle Modifications: Weight management, regular low-impact exercise (walking, swimming), and elevation of the legs.\nCompression Therapy: The use of medically prescribed compression stockings when recommended.\nDietary Awareness: A fiber-rich diet to prevent constipation and straining.\nBy integrating FLAVOSHIELD 500 into this comprehensive approach, individuals can take proactive control of their venous health, shielding their vitality and comfort from the burdens of venous insufficiency. Always consult your healthcare provider to determine if FLAVOSHIELD 500 is appropriate for your specific condition and to establish the correct dosage and treatment duration.\n\nDisclaimer: This content is for informational purposes only and does not constitute medical advice. Always seek the guidance of a qualified healthcare professional with any questions regarding a medical condition or treatment. Do not delay seeking or disregard professional medical advice based on information contained here.", "price": 218.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2250, "imageuri": "https://productimages.withfloats.com/actual/6948e7392f14bd83555d1409.png", "tileimageuri": "https://productimages.withfloats.com/tile/6948e7392f14bd83555d1409.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T06:37:44.038Z", "updatedon": "2025-12-22T06:37:44.038Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/micronized-purified-flavonoid-fraction-mpff-tablets-450mg-diosmin-50mg-hesperidin/2250", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FLAVOSHIELD 500", "category": "Gerneral", "tags": [ "A Deep Dive into Advanced Venous and Vascular Wellness", "human circulatory system", "blood to the heart against gravity.", "Powered by a Micronized Purified Flavonoid Fraction (MPFF)", "Hemorrhoidal Disease", "By reducing blood viscosity and inhibiting red blood cell aggregation", "holistic health strategy.", "Chronic Venous Insufficiency (CVI)", "Varicose Veins", "Hemorrhoids (Piles)", "Venous Ulcers", "Lymphedema", "Post-Surgical Venous Recovery" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Imatinib IP 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2025-12-18T07:41:25.851Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imatinib-ip-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }